BMI View: Poland will remain one of the most attractive pharmaceutical and healthcare markets in the
CEE region. Strong economic growth and the introduction of a tax-funded healthcare system will support
strong market growth. Opportunities for innovative drugmakers wi ..."
BMI View: The impending shift to a tax-based healthcare system will provide enticing revenue earning
opportunities for multinational pharmaceutical firms operating in Poland, while the country's increasing
pensionable population will drive demand in high-value medicin ..."
BMI View: The Polish healthcare system faces significant reform under the newly elected Law and Justice
party. We believe that a transition from Poland's current insurance based healthcare system to a tax
financed healthcare system will be broadly positive for all sta ..."
Compare the operations and specialisations of public hospitals currently active in all 16 voivodships of the Polish market using this comprehensive and efficient report. It contains information on the number, locations and types of public hospitals, saturation levels of popular m ..."
BMI View: A positive economic outlook and strong pharmacy sales data for Poland in the first quarter of
the year reaffirms our outlook for a pickup in pharmaceutical sales growth in 2015. With the National
Health Fund expanding its reimbursement expenditure and Polish ..."
BMI View: The National Health Fund and the Agency for Health Technology Assessment will continue to
impede the reimbursement of innovative drugs in Poland over the short term, given their current focus on
budgetary restraint. Over the longer term, we expect these budg ..."
Evaluate conditions in Poland's market for private healthcare as of 2015.
Report lists key service providers, forecasts development during 2015-2020.
As private health insurance, medical subscription services, hospitals and medical services providers are mentio ..."
Explore value, regulatory changes in Poland's market for dentistry services.
Report analyses key services segments and offers forecasts for development in 2015-2020.
Consult PMR's latest publication for an assessment of the dental health status of the Polish public and thei ..."
BMI View: The Polish pharmaceutical market is heavily dependent on public healthcare spending; any
negative economic developments will have an impact on the market in the short term. Over the past five
years, Poland's economic outperformance has been vital to maintain ..."
BMI View: Released retail pharmacy and national health insurance reimbursement data supports our
earlier assertion of a rebound in Q214 and reinforces our full-year forecast for pharmaceutical sales in
Poland. We see unemployment trending downwards and rising househol ..."